Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5202790
Max Phase: Preclinical
Molecular Formula: C40H56N10O12S
Molecular Weight: 901.01
Associated Items:
ID: ALA5202790
Max Phase: Preclinical
Molecular Formula: C40H56N10O12S
Molecular Weight: 901.01
Associated Items:
Canonical SMILES: CCC(CC)[C@@H]1NC(=O)CNC(=O)[C@@H]2Cc3c([nH]c4ccccc34)SC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N2
Standard InChI: InChI=1S/C40H56N10O12S/c1-4-19(5-2)33-37(60)43-13-30(55)44-26-17-63-39-22(21-8-6-7-9-23(21)47-39)11-24(34(57)42-14-31(56)48-33)45-38(61)32(18(3)28(53)16-51)49-36(59)27-10-20(52)15-50(27)40(62)25(12-29(41)54)46-35(26)58/h6-9,18-20,24-28,32-33,47,51-53H,4-5,10-17H2,1-3H3,(H2,41,54)(H,42,57)(H,43,60)(H,44,55)(H,45,61)(H,46,58)(H,48,56)(H,49,59)/t18-,20+,24-,25-,26-,27-,28-,32-,33-/m0/s1
Standard InChI Key: RXZKMPBJFBXRGA-ITBSNWBQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 901.01 | Molecular Weight (Monoisotopic): 900.3800 | AlogP: -4.25 | #Rotatable Bonds: 8 |
Polar Surface Area: 343.58 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.13 | CX Basic pKa: | CX LogP: -5.43 | CX LogD: -5.43 |
Aromatic Rings: 2 | Heavy Atoms: 63 | QED Weighted: 0.12 | Np Likeness Score: 1.02 |
1. Todorovic M, Rivollier P, Wong AAWL, Wang Z, Pryyma A, Nguyen TT, Newell KC, Froelich J, Perrin DM.. (2022) Rationally Designed Amanitins Achieve Enhanced Cytotoxicity., 65 (15.0): [PMID:35696491] [10.1021/acs.jmedchem.1c02226] |
Source(1):